Urinary incontinence is a common and distressing condition that is known to adversely affect quality of life.
Overactive bladder (OAB) is the term used to describe the symptom complex of urgency with or without urge incontinence, usually with frequency and nocturia. Drug therapy, in addition to behavioral modification, remains integral in the management of women with OAB, and the development of new drugs, treatment regimens and methods of delivery should improve patient compliance and acceptability. Developments over the last 10 years have led to the launch of several new drugs for the treatment of OAB that may offer greater efficacy while minimizing adverse effects. This article critically reviews the current pharmacological treatment of OAB in addition to providing a rationale for treatment.
Written by:
Robinson D, Cardozo L. Are you the author?
Kings College Hospital, Department of Urogynaecology, 3rd Floor, Golden Jubilee Wing, London, UK.
Reference: Expert Rev Clin Pharmacol. 2008 Jan;1(1):163-75.
doi: 10.1586/17512433.1.1.163
PubMed Abstract
PMID: 24410519
UroToday.com Overactive Bladder (OAB) Section
